Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000950170-25-072765·Dianthus Therapeutics, Inc. /DE/
Schedule 13G ownership disclosure
DIANTHUS THERAPEUTICS INC COM
Common Stock, par value $0.001 per share · CUSIP: 252828108
Event date: 2025-03-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- TCG Crossover GP II, LLC
Shares: 1,501,624 · Class: 4.7%
- TCG Crossover Fund II, L.P.
Shares: 1,501,624 · Class: 4.7%
- Chen Yu
Shares: 1,501,624 · Class: 4.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-25-072765
- Form type
- SCHEDULE 13G/A
- Filer
- Dianthus Therapeutics, Inc. /DE/
- CIK
- CIK 1690585
- Filed
- May 15, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership